Abstracts Archive - Page 1345 of 2425 - ACR Meeting Abstracts

Abstract Number: 2092 • 2017 ACR/ARHP Annual Meeting
Pilot Clinical Study of a Novel Unobtrusive Carpal Tunnel Tissue Manipulation Device in Reducing Symptoms of Carpal Tunnel Syndrome
Pauline Luong^1,2, Frank King³, Zong-Ming Li^2,4, Matt Dickason⁵, Matthew Diamond⁶ and Jae Son^1,2, ¹Pressure Profile Systems, Los Angeles, CA, ²Sohn Inc, Los Angeles, CA, ³Mission Pain and Spine Institute, Mission Viejo, CA, ⁴Biomedical Engineering, Orthopaedic Surgery, and Physical Medicine & Rehabilitatio, Cleveland Clinic, Cleveland, OH, ⁵Renaissance Associates, Newport Beach, CA, ⁶Rusk Institute of Rehabilitation Medicine, NYU School of Medicine, San Francisco, CA
Background/Purpose: Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy and has been associated with systemic conditions such as rheumatoid arthritis, hypothyroidism, and…
Abstract Number: 2093 • 2017 ACR/ARHP Annual Meeting
Comparison of Clinical and Laboratory Features of Patients with and without Allergic Conditions in IgG4-Related Disease: A Single-Center Experience in Japan
Takako Saeki, Tomoyuki Ito, Maasa Tamura, Seiichi Yoshikawa and Hajime Yamazaki, Department of Internal Medicine, Nagaoka Red Cross Hospital, Nagaoka, Japan
Background/Purpose: Although patients with IgG4-related disease (IgG4-RD) sometimes have accompanying allergic conditions, few data on the relationship between allergic conditions and IgG4-RD have been available.…
Abstract Number: 2094 • 2017 ACR/ARHP Annual Meeting
Prevalence of Organ Involvement in Mixed Connective Tissue Disease
Javier Narváez¹, Maria Pascual², Gloria Albert Espi³, Milena Millan⁴, Mercè López de Recalde⁵, Juan José Alegre⁶, Ivan Castellví⁷, Carmen Gomez Vaquero⁵ and Joan Miquel Nolla⁸, ¹Rheumatology Department, Hospital de Bellvitge. Barcelona. Spain, L’Hospitalet de Llobregat, Spain, ²Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain, ³Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain, ⁴Rheumatology, Hospital de Sant Pau, Barcelona, Spain, ⁵Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ⁶Sección de Reumatología Hospital Universitario Dr Peset Valencia, Valencia, Spain, ⁷Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain, ⁸Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain
Background/Purpose: : Mixed connective tissue disease (MCTD) is characterized by overlapping features of SLE, SSc, PM/DM and rheumatoid arthritis together with the presence of high-titre…
Abstract Number: 2095 • 2017 ACR/ARHP Annual Meeting
Traditional Disease Modifying Anti-Rheumatic Drugs (tDMARDs), Hydroxychloroquine (HCQ) and/or Sulfasalazine (SSZ), Are Rapidly Effective in Immune Checkpoint Inhibitors-Induced Inflammatory Arthritis
Jessie Alperin¹, Jeffrey Sarazin², Leslie Fecher³, Christopher Lao³, Seetha Monrad⁴, David Fox¹ and Elena Schiopu⁵, ¹University of Michigan Medical System, Ann Arbor, MI, ²Rheumatology, University of Michigan Medical System, Ann Arbor, MI, ³Oncology, University of Michigan Medical System, Ann Arbor, MI, ⁴Internal Medicine/Rheumatology, University of Michigan Medical System, Ann Arbor, MI, ⁵Internal Medicine, University of Michigan Medical System, Ann Arbor, MI
Background/Purpose: Immune checkpoint inhibitor (ICI) therapy is widely used in the treatment of metastatic melanoma and non-small cell lung cancer and it is under investigation…
Abstract Number: 2096 • 2017 ACR/ARHP Annual Meeting
Nailfold Capillaroscopy Is an Opportunity for Telerheumatology
Jacob R. Stever¹, Nicholas Lebedoff², Tracy M. Frech³, Lesley A. Saketkoo⁴ and Marcus Snow⁵, ¹Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ²Internal Medicine, University of Utah, Salt Lake City, UT, ³Division of Rheumatology, University of Utah, Salt Lake City, UT, ⁴Rheumatology, Tulane University School of Medicine, New Orleans, LA, ⁵Internal Medicine, University of Nebraska, Omaha, NE
Background/Purpose: The 2013 classification criteria for systemic sclerosis (SSc) provide 2 points (towards a 9 point diagnosis) for patients who have abnormal capillaroscopy. In the…
Abstract Number: 2097 • 2017 ACR/ARHP Annual Meeting
Clinical Significance of KL-6 and SP-D As Serum Markers for Interstitial Lung Disease in Patients with Connective Tissue Disease
Kyung-Eun Lee¹, Ji-Hyoun Kang², Dong-Jin Park² and Shin-Seok Lee², ¹Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)
Background/Purpose: To evaluate the association between serum levels of Krebs von den Lungen-6 (KL-6) and surfactant protein-D (SP-D) and the clinical manifestations and severity of…
Abstract Number: 2098 • 2017 ACR/ARHP Annual Meeting
Systemic Treatment for ACUTE Anterior Uveitis ( SYNTHETIC AND BIOLOGIC DISEASE-MODIFYINGANTIRHEUMATIC DRUGS) : A Systematic Literature Review
Alejandro Gómez-Gómez¹, Estibaliz Loza², Maria P Rosario³, Gerard Espinosa⁴, Jose M Ruiz de Morales⁵, Jose M Herreras⁶, Santiago Muñoz⁷ and Miguel Cordero-Coma⁸, ¹Hospital Universitario Infanta Sofía, Madrid, Spain, ²Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain, ³Instituto de Salud Musculoesquelética, Madrid, Spain, ⁴Autoimmune Diseases Department. Hospital Clínic de Barcelona, Barcelona, Spain, ⁵Complejo Asistencial Universitario de León, León, Spain, ⁶Ophthalmology, Hospital Universitario, IOBA, Valladolid, Spain, ⁷Rheumatology, Hospital Infanta Sofia, Madrid, Spain, ⁸Ophthalmology, Hospital de León. Spain, León, Spain
Background/Purpose: Acute anterior uveitis (AAU) is the most common form of uveitis. One third of AAU patients may present recurrences, some requiring systemic disease-modifying antirheumatic…
Abstract Number: 2099 • 2017 ACR/ARHP Annual Meeting
Elderly – Onset Sarcoidosis: a Single Center Comparative Study
Senol Kobak¹, Fidan Yildiz², Huseyin Semiz³ and Mehmet Orman⁴, ¹Rheumatology, Istinye University Faculty of Medicine, Istanbul, Turkey, ²Chest Diseases, Medicalpark Hospital, İzmir, Turkey, ³Internal Medicine, Ege University Faculty of Medicine, İzmir, Turkey, ⁴Statistics, Ege University Faculty of Medicine, İzmir, Turkey
Background/Purpose: Sarcoidosis is a chronic granulomatous inflamatory disease characterized with non-caseified granuloma formation. It is rarely affects patients older than 65 years old..The purpose of…
Abstract Number: 2100 • 2017 ACR/ARHP Annual Meeting
An International Consensus Exercise to Develop Candidate Items for Classification Criteria in Relapsing Polychondritis
Marcela A. Ferrada¹, Peter A. Merkel², Keith A. Sikora³, Robert Colbert⁴, Chikashi Terao⁵, Hajime Yoshifuji⁶, Toshiki Nakajima⁷, Aman Sharma⁸, Shirish Sangle⁹, Dax Rumsey¹⁰, Christian Pagnoux¹¹, Larry Young¹², Colleen K. Correll¹³, Fabien Maldonado¹⁴, Robert Lebovics¹⁵, Alexander Gelbard¹⁴, Philip Zapata¹⁶, Allen Clint¹⁷, Otis Rickman¹⁴, Nitin Seam¹⁷, Guillaume Moulis¹⁸, Nathalie Costedoat-Chalumeau¹⁹, Clement J. Michet Jr.²⁰, James D. Katz²¹ and Peter C. Grayson²¹, ¹NIAMS, National Institues of Health, Bethesda, MD, ²Division of Rheumatology, University of Pennsylvania, Philadelphia, MN, ³Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ⁴National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ⁵Departments of Genetics and Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁶Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, ⁷Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, ⁸Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, ⁹Louise Coote Lupus Unit, Rheumatology and Lupus, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom, ¹⁰Stollery Children's Hospital, Edmonton, AB, Canada, ¹¹Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ¹²Medicine, University of Miami Miller School of Medicine, Miami, FL, ¹³University of Minnesota, Minneapolis, MN, ¹⁴Vanderbilt University Medical Center, Nashville, TN, ¹⁵Mt. Sinai St. Luke's Hospitals, New York, NY, ¹⁶The George Washington University School of Medicine and Health Sciences, Washington, DC, ¹⁷National Institutes of Health, Bethesda, MD, ¹⁸CIC 1436, Toiulouse, France, ¹⁹Service de médecine interne Pôle médecine, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares de l’île de France, Paris, France, ²⁰Division of Rheumatology, Mayo Clinic, Rochester, MN, ²¹National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD
Background/Purpose: There are no validated classification criteria for relapsing polychondritis (RP). Given that some manifestations of RP are organ- or life-threatening, it is imperative that…
Abstract Number: 2101 • 2017 ACR/ARHP Annual Meeting
The Clinical Characteristics of IgG4 Related Disease in China: With 346 Cases Reported
Panpan Zhang¹, Wen Zhang², Jizhi Zhao³, Mu Wang³, Ruie Feng³, Xiaowei Liu³, Xuemei Li³, Yamin Lai³, Xuejun Zeng³, Juhong Shi³, Huijuan Zhu³, Huadan Xue³, Wei Zhang³, Hua Chen⁴, Yunyun Fei³, Linyi Peng³, Xiaofeng Zeng⁵ and Fengchun Zhang³, ¹Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China, ²Rheuamtology, Peking Union Medical College Hospital, Beijing, China, ³Peking Union Medical College Hospital, Beijing, China, ⁴Rheumatology, Peking Union Medical College Hospital, Beijing, China, ⁵Rheumatology, Peking Union Medical College and Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China
Background/Purpose: To study the clinical characteristics of IgG4-RD patients in China Methods: Patients were recruited from a prospective cohort study of IgG4-RD in Peking Union…
Abstract Number: 2102 • 2017 ACR/ARHP Annual Meeting
The Difference between International Criteria for BD (ICBD) and the BD Criteria of International Study Group (ISG) in Our Behcet’s Disease (BD) Patients Who Fulfilled Japanese BD Criteria
Tsuyoshi Kobashigawa, Yuki Nanke, Hisashi Yamanaka and Shigeru Kotake, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: In Japan, we have a criteria for BD since 1988. (International Journal of Tissue Reactions. 1988: 10; 59-65.) In Japanese patients diagnosed according to…
Abstract Number: 2103 • 2017 ACR/ARHP Annual Meeting
Problems in the Diagnosis of Familial Mediterranean Fever in Turkey
Mustafa Erdogan¹, Yesim Ozguler¹, Elif Dincses², Sinem Nihal Esatoglu¹, Gul Guzelant¹, Guzin Karatemiz¹, Serdal Ugurlu³, Gulen Hatemi¹, Huri Ozdogan¹, Hasan Yazici¹ and Emire Seyahi¹, ¹Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey, ³Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
PROBLEMS IN THE DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER (FMF) IN TURKEYBackground/Purpose: The diagnosis of FMF can be missed or delayed even in a country like…
Abstract Number: 2104 • 2017 ACR/ARHP Annual Meeting
Exposure to Fine Particle Air Pollution and Anti-Nuclear Antibodies (ANA) in a Large Population-Based Sample
Sasha Bernatsky¹, Audrey Smargiassi², Lawrence Joseph³, Patrick Belisle³ and Marvin J. Fritzler⁴, ¹Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ²Université de Montreal, Montreal, QC, Canada, ³Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ⁴Medicine, University of Calgary, Calgary, AB, Canada
Background/Purpose: Fine particle air pollution (PM2.5) has been associated with many conditions including systemic autoimmune rheumatic diseases. Our work has previously suggested an association between…
Abstract Number: 2105 • 2017 ACR/ARHP Annual Meeting
Epidemiology of Interstitial Pneumonia with Autoimmune Features
Robert Mango¹, Ashima Makol², Cynthia S. Crowson³, Jay H. Ryu⁴ and Eric L. Matteson², ¹Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, MN, ²Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁴Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: Interstitial pneumonia with autoimmune features (IPAF) is a subset of interstitial lung disease (ILD) with clinical features suggestive of, but not sufficient for, a…
Abstract Number: 2106 • 2017 ACR/ARHP Annual Meeting
Immune-Related Adverse Events in Cancer Patients Treated with Immune Check Point Inhibitors: A Single Center Experience
Taylor Doberstein¹, Aneet Kaur¹, Elizabeth Field² and Namrata Singh³, ¹Internal Medicine, University of Iowa, Iowa City, IA, ²Iowa City VA, Iowa City, IA, ³Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA
Background/Purpose: The immune checkpoint inhibitors (ICIs) anti-CTLA4 (cytotoxic T-lymphocyte associated protein 4) and anti-PD1 (programmed death cell protein 1) have revolutionized cancer treatment. ICIs interrupt…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].